Show simple item record

dc.contributor.authorMcNamara, Mairead G
dc.contributor.authorFrizziero, Melissa
dc.contributor.authorJacobs, Timothy
dc.contributor.authorLamarca, Angela
dc.contributor.authorHubner, Richard A
dc.contributor.authorValle, Juan W
dc.contributor.authorAmir, E
dc.date.accessioned2019-04-29T09:49:00Z
dc.date.available2019-04-29T09:49:00Z
dc.date.issued2019en
dc.identifier.citationMcNamara MG, Frizziero M, Jacobs T, Lamarca A, Hubner RA, Valle JW, et al. Second-line treatment in patients (pts) with advanced extra-pulmonary poorly differentiated neuroendocrine carcinoma (EP-PD-NEC): a systematic review and meta-analysis. Neuroendocrinology. 2019;108:188.en
dc.identifier.urihttp://hdl.handle.net/10541/621795
dc.language.isoenen
dc.titleSecond-line treatment in patients (pts) with advanced extra-pulmonary poorly differentiated neuroendocrine carcinoma (EP-PD-NEC): a systematic review and meta-analysisen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentUniversity of Manchester/The Christie NHS Foundation Trust, Manchester, United Kingdomen
dc.identifier.journalNeuroendocrinologyen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record